Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
iTeos Therapeutics, Inc. Banner

iTeos Therapeutics, Inc.

ITOS Stock Analysis

Page title

Section title

Breakdown
2018
2019
2020
2021
2022
2023
Net Income
-18.057m-22.454m-38.033m214.521M96.652M-112.642m
Depreciation & Amortization
505.000K611.000K535.000K603.000K803.000K898.000K
Change in Working Capital
-1.856m-1.082m9.330M284.210M-228.491m-8.799m
Operating Cash Flow
-19.097m-23.145m-25.176m513.140M-111.193m-103.756m
Capital Expenditure
-226.000k-721.000k-356.000k-1.181m-938.000k-2.966m
Free Cash Flow
-19.323m-23.866m-25.532m511.959M-112.131m-106.722m
Debt Repayment
0.0000.0000.0000.0000.0000.000
Dividends Paid
0.0000.0000.0000.0000.0000.000
Common Stock Issued
23.330M22.474M213.660M2.943M925.000K1.113M
Common Stock Repurchased
-226.000k0.000-332.000k0.0000.0000.000
Net Change in Cash
3.237M-2.064m316.464M512.381M-563.797m-33.587m